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Introduction
In 2009 in the United States, breast cancer (BC) was the most common cancer in women,
and colorectal cancer (CRC) was the third most common cancer in both men and women
(Jemal et al. 2009). Among all cancers, both BC and colorectal cancer (CRC) can be
detected in early stages through effective screening methods. However, both breast and
colorectal cancer screening rates are lower than optimal, resulting in later stage cancers at
first diagnosis (ACS, 2011). Currently, 40% of all BC and 61% of all CRC in the United
States is diagnosed at a nonlocalized stage, which is associated with a lower five-year
survival rate (ACS, 2011; Henley et al, 2010; Richardson et al, 2011).
Inadequate BC screening and access barriers to screening may lead to more advanced stage
breast cancer diagnosis and poorer survival (Taplin et al, 2004). Utilization of CRC
screening varies by race or ethnicity, education, health insurance coverage, and immigration
status. Hispanics, those with less than a high school education, those without health
insurance, and immigrants who had been in the US for fewer than 10 years were the least
likely to have utilized CRC screening in 2008 (ACS, 2011). Late-stage cancer diagnosis
results in higher morbidity and mortality than would obtain with optimal cancer screening
utilization. Because these cancers typically occur at older ages, and the population size and
life expectancy of older people continues to increase, (Administration on Aging, 2006;
Hetzel and Smith, 2001) it is likely that the morbidity and mortality burden from these
cancers will continue to increase. Thus, to improve BC and CRC outcomes it is urgent that
we develop strategies to identify certain higher-risk locations, so that geographic disparities
might be reduced.
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In this paper we consider the substantial variation that exists across states in geopolitical
variables such as cancer control policies or state insurance regulations. We examine how
these interact with other, more locally defined socio-ecological variables to predict the
prevalence of late-stage cancer. We find that state environments significantly alter the effect
estimates associated with deprivation or social support on breast and colorectal cancer stage
at diagnosis. This geopolitical aspect of the cancer control problem contributes significantly
to the observed geographic disparities, and has never been studied previously.
Geographic disparities in breast and colorectal cancer prevention and outcomes have existed
for decades (Kerner et al, 1988; ACS 2010, 2011; Naishadham et al. 2011). As early as
1988, Kerner et al. called for using spatial analytic methods to inform targeted neighborhood
interventions in comprehensive cancer control (CCC) efforts to increase national cancer
screening rates. Since that time, elimination of disparities in cancer screening and outcomes
has been a particular focus of CCC efforts (Coughlin et al. 2006). However, despite the
identified need for more widespread use of spatial analytic methods to inform place-targeted
interventions, at the present time, no materials developed to guide CCC activities have
addressed spatial variation in cancer prevalence, and less than a dozen states include
geographic information systems or spatial analysis in their CCC plan activities (CDC, 2006;
Given et al., 2005). However, some states have recently begun small-area analyses to
identify local areas with higher incidence or late-stage diagnosis of cancers.
The spatial analytic methods employed to date in these small-area analyses have been
primarily descriptive. For example, a few states have used various types of spatial statistics
or small-area analysis to describe patterns in cancer incidence or late stage diagnoses (Beyer
and Rushton, 2009; New Jersey Comprehensive Cancer Control Plan (2008-2012), which
cites an earlier study by Roche et al, 2002; and the Komen Foundation (2011)). These
studies have provided evidence that spatial patterns vary considerably across geographic
scales that are smaller than counties. Such studies are useful for highlighting more specific
locations (than counties) where prevalence or incidence rates are higher within states.
However, they do not provide information regarding why these patterns may have occurred,
based on underlying socioecological factors. Because spatial analytic methods have not been
used in predictive analyses that explicate Where, Why, and for Whom we observe these
disparities, they persist and result in undue suffering and inefficient use of healthcare
resources.
Morever, state-specific analyses are not informative as regards national comprehensive
cancer control efforts. The focus on states is an outgrowth of the decentralized approach to
cancer control efforts that has been adopted in the US. The methods used in this paper allow
for comparisons across states, so that we can begin to see how states compare to one another
and where or how a more centralized national comprehensive cancer control policy might
direct targeted resources. We use spatial analysis to answer questions related to both Where
and Why disparities in late-stage breast and CRC diagnoses are observed. In examining
Why, we include person, county, and state level characteristics in a model examining the
impacts of these factors. We include state-level variables reflecting characteristics of states’
cancer control planning, insurance markets and managed care environments to help model
the spatial heterogeneity in observed late-stage cancer incidence from place to place. To
answer questions related to Where disparities in late-stage BC and CRC are observed, we
generate county level robust predictions of late-stage BC and CRC rates from a random-
intercept multilevel model. We then use these predicted rates to show the geographic
variation in the rates among the cancer populations in the 11 Surveillance, Epidemiology,
and End Results (SEER) Registry populations that we study.
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The importance of including several levels of factors in the empirical model is motivated by
a conceptual model which addresses two concerns raised in the recent literature. First,
Cummins et al (2007) note that recent empirical research focusing on the role of place in
shaping health and health inequalities has had a limited focus on isolating the independent
contribution of place-level and individual-level factors. They argue that research in place
and health should instead recognize the “mutually reinforcing and reciprocal relationships
between people and place” (e.g. spatial interaction among people and environments). The
notion that interactions between race and place may influence social outcomes is not new
(Probst et al., 2004), but other environmental interactions remain largely unexplored
(Cummins et al, 2007).
Second, there may be many important dimensions governing the social determinants of
disparities, including the broader dimension of regional opportunities, which is largely
overlooked in literature to date (Osypuk and Acevedo-Garcia, 2010). Our conceptual model
(Figure 1) makes explicit the multiple levels of influence, including the state and larger
regional-level factors. While multi-state regimes reflecting regional opportunities are likely
to influence cancer outcomes, the 11 SEER Registry populations we study here are
geographically disparate and preclude analysis of these fourth-level regional factors.
Figure 1 describes spatial interaction in the United States among people and characteristics
of their contextual environments along the pathways to health prevention and subsequent
outcomes. This model is a hybrid which merges the behavioral model of utilization (Aday &
Andersen, 1974) with a model of spatial interaction adopted by the World Health
Organization (Khan & Bhardwaj, 1994). Different levels of influence are also present. State
factors at the third level are used to reflect the fact that each state in the Unites States
oversees a cancer control program that is decentralized in terms of funding and
implementation. Also, in the United States, state health care environments are
heterogeneous, governed by local and regional politics, state-specific health insurance
regulation and mandates, social systems, market-level forces that determine supply factors,
and community- level forces that determine social factors. Individuals exhibit predisposing,
enabling, and need characteristics, all of which interact with the forces in the broader
system. The factors that existed at the time and in the place of initial cancer diagnosis are
most relevant for our research questions.
As noted in the literature, when cancer screening rates are lower, incidence of late-stage
cancers at first diagnosis will be more common. However, the empirical relationship is
confounded by the fact that higher screening rates increase probability of detection and the
observed number of cancers and late-stage cancers, relative to their true incidence, which is
unobserved. Thus when explaining late-stage cancer incidence rates in small areas, it is
important to control statistically for utilization of cancer screening among the population.
Cancer prevention (screening) is governed by the same factors as cancer outcomes
(observed cancer stage or mortality) but screening may occur along the pathway to
outcomes. Thus cancer screening is an important control factor to include in the modeling of
the final outcome, cancer stage at first diagnosis. In Figure 1, utilization of screening is
along the pathway but not necessarily encountered by all persons, reflected in the wide
arrow connecting the socioecological system and outcomes.
We are particularly interested in an understudied area: how the state-level variation in health
insurance environments (Level 3) is predictive of cancer outcomes. Health insurance
mandates are controversial but numerous, including services mandates (e.g., alcohol
treatment), provider mandates (e.g., chiropractors) and coverage mandates (e.g. BC
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screening or inpatient stay following mastectomy). For example, all states except one (Utah,
during the time interval we study) mandated that health insurance cover BC screening
(NCSL, 2011). Health insurance regulatory environments vary considerably across states,
and several studies have examined the impacts of insurance regulation and mandates on
insurance premiums and rates of uninsured individuals (CBO, 2005; Kowalski et al., 2008;
LaPierre et al., 2009; New, 2006). One study concluded that opening up competition among
plans across states would lower premiums and increase value in the benefits packages
offered to consumers (Parente et al., 2008).
No published studies concerning population cancer outcomes have included state-level
factors or examined state-level variation in health insurance market or health policy factors
and their impacts on cancer prevention and outcomes. Our theory is that because health
insurance regulation and mandates impact information to consumers and perceptions of the
need for certain screening tests, prices (premiums), free choice of providers, and plan
coverage, they have downstream impacts on preventive care behaviors, satisfaction with
providers, treatments received and quality of care. This health economics area of research
has been ignored in the literature on cancer prevention and outcomes, and is a unique
contribution from this paper. This research is critically important as our nation grapples with
healthcare reforms and searches for those most efficacious in allocating limited resources
(Weil and Tallon, 2008).
Methods
Study Sample
We used data describing the SEER Registry populations in the 11 states covered (CA, CT,
IA, KY, LA, NJ, NM, and UT) or partially covered (GA, MI, WA) by the Registries at the
time of our study. The study population includes persons of all ages diagnosed with BC or
CRC between 2000 and 2005 who were eligible for any form of Medicare or Medicaid
insurance. Medicare covers the vast majority of persons aged 65+, and other younger
individuals who have disabilities or end-stage renal disease, while Medicaid covers low-
income individuals and in some states helps elderly persons pay for their Medicare
insurance. According to the SEER-Medicare documentation, 94% of persons aged 65+ are
linked to Medicare enrollment files. Thus, the study sample includes virtually the entire
population of persons aged 65+ with known cancers in these SEER Regions. The study
population does include individuals younger than age 65, but only those who were entitled
through low income, disability, or End-Stage Renal Disease (ESRD) to receive Medicare or
Medicaid benefits. Thus the study sample is not representative of the under age 65
population with cancer, but it is quite representative of those aged 65+ who have cancer in
these SEER regions. However, because BC and CRC cancer incidence rates are much higher
for persons aged 65+ (Howlader et al, 2011), the sample is quite representative of persons
with cancer in these SEER regions. For CRC, the age-adjusted incidence ratesi for new cases
per 100,000 persons are much lower for persons under age 65 (11.5) than for persons and
aged 65+ (188.9); for BC these are 23.2 and 84.2, respectively. Because incidence rates for
breast and colorectal cancers increase with age, we would also expect that rates of late-stage
diagnosis for these cancers would increase with age.
In some states (GA, MI, WA) the SEER Registries did not include residents from all over
the state at the time of our study. The Georgia population includes the urban Atlanta
metropolitan area and some selected rural counties, while the Michigan population includes
metropolitan Detroit, and Washington includes both some urban and rural areas. Thus the
iIncidence rate = (New cancers / Population) × 100,000
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study population is quite representative of persons aged 65+ in eight states ( CA, CT, UT,
LA, IA, KY, NJ, NM) but representative only of subpopulations of persons aged 65+ in the
remaining three states (GA, MI, WA).
For people who had multiple cancer diagnoses, we selected only those whose first diagnosis
was either BC or CRC and whose cancer was staged at time of diagnosis. The sample
included 116,121 women with BC and 106,224 men and women with CRC as their primary
cancer diagnosis and recorded stage at diagnosis. At the time of their first cancer diagnosis
during 2000-2005, these people resided in the SEER Registry areas of the 11 states we
study. The address at time of cancer diagnosis was used to assign state and county
contextual variables.
Data Sources
The SEER Registries provide rich information for the population with cancer diagnoses,
including month and year of cancer diagnosis, cancer site, histological type, cancer stage
information (including ‘unstaged’), county of residence at time of primary cancer diagnosis,
mortality status, and patient demographics. County data linked to persons in the multilevel
modeling come from an extensive online geospatial database (http://rtispatialdata.rti.org).
State insurance data come from the National Coalition of State Legislatures (NCSL, 2011).ii
The Comprehensive Cancer Control (CCC) plan inception year data were obtained from
Comprehensive Cancer Control Plans: A Content Review (CDC, 2005). InterStudy was the
source for county-level managed care insurance plan penetration.
Measures
Person-level variables—The information on cancer stage is from SEER Summary Stage
2000, which we defined for the analysis as a dichotomous outcome variable: late-stage
versus early-stage. Late-stage included regional and distant stage, whereas the early-stage
includes the in-situ and localized diagnosis. Cases with unstaged cancers were dropped,
consistent with other geographic studies of late-stage cancer incidence (McLafferty and
Wang, 2009; Meliker et al, 2009; Wange et al, 2008). In our data, rates of late-stage BC
range from a low of about 26% in Connecticut to a high of about 33% in Louisiana. Rates of
late-stage CRC range from a low of about 49% in Utah to a high of about 58% in
Washington state (Table 1).
We used the SEER-Medicare linked data, which provides demographic information
including type of health insurance (Medicare traditional fee-for-service (FFS), dual
eligibility for Medicare/Medicaid, Medicare managed care planiii) and includes all persons,
regardless of age, who have some sort of Medicare or Medicaid coverage or eligibility.
Demographic information on subjects included age, race or ethnicity, marital status, original
reason for Medicare entitlement, and an indicator of whether the state provided special
iiSee: National Conference of State Legislatures (NCSL), (May 2011). “Managed Care State Laws and Regulations, Including
Consumer and Provider Protections”, available online November 2011: , http://www.ncsl.org/default.aspx?tabid=14320
This summary compilation of state laws and polices was originally published 2000, with regular updates and additions through 2005.
Because states enacted far fewer changes in this area since 2005, this report is no longer maintained on a regular basis. It remains an
accurate historical view of the range of state-specific initiatives in an era where there was relatively little federal law. The 2010
Affordable Care Act, which is a federal law, substantially adds to the regulatory requirements in some of the areas covered in this
report. See NCSL's latest (2010-2011) reports and descriptions online at the NCSL Health Reform website, http://www.ncsl.org/
Default.aspx?TabID=160&tabs=831,139,1156#1156.
iiiMedicare traditional FFS insurance allows beneficiaries to utilize any provider or hospital that is willing to serve them, while
Medicare managed care plans require beneficiaries to go to preferred providers and facilities associated with the plans, which are
offered by private insurance companies who are reimbursed by Medicare. Seniors have choice over these two types of coverage in an
annual insurance enrollment period. Medicaid is health insurance coverage for certain low income people or disabled individuals,
offered separately by states with various eligibility requirements. People covered by both Medicare and Medicaid are considered
‘dually eligible’.
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financial assistance. People receiving special assistance are generally low income, disabled,
or have end-stage renal disease (ESRD) and are called ‘dually eligible’ (for both Medicare
and Medicaid) (MEDPAC, 2004). This group is defined as our ‘vulnerable’ cancer
subpopulation. Marital status and dual eligibility indicators were defined in the year of
cancer diagnosis.
Table 1 provides sample statistics, by state, including the number of persons included in the
Registry sample, the number of counties in the state with registry population residences, and
proportions of demographic variables for each state's registry population. We define and use
three racial or ethnic groups (whites, Blacks, and all others). The aggregation across races
and ethnicities in the ‘others’ category (which also includes persons of unknown race) was
unfortunately necessary due to small numbers of sample members of certain races or
ethnicities in some counties and states. This is an empirical constraint imposed by these
data; in particular, there were too few persons of Hispanic origin in each and every state to
break this category out. An earlier paper by Kuo, Mobley, and Anselin (2011) looking only
at California women with late-stage BC was able to break out Hispanic women as a separate
group, because group subpopulations in this state were large enough to confer the statistical
power necessary to differentiate among them and whites. However another paper examining
late-stage cancers among seniors across the SEER Registry areas was not able to break this
group out both by state and ethnicity, and pooled data across all states in order to examine
minority status effects (Haas et al, 2008). Because we include three levels in the multilevel
model used in this paper, having such sparse cells in some states caused failure to converge.
Our main interest is in the insurance market interaction effects, which necessitates keeping
states as separate entities in the modeling, thus we cannot provide finer racial or ethnic
group breakouts than the three groups (white, Black, all others).
About 40% of the cases studied were residents of California, with New Jersey providing the
next largest group. Three states – GA, MI, and WA – are only partially covered by the
SEER registries so their cancer patients don't represent their entire states. California,
Louisiana, and Kentucky show the highest proportions of vulnerable, dually eligible cancer
patients.
Geographic Risk Factors—In specifying the empirical models parsimony was essential,
otherwise the models would not be estimable. We first looked at simple correlations among
many possible variables, and thought about hypothetical relationships and interactions based
on the literature. The final models are parsimonious but reflect key elements from Figure 1,
the conceptual model. The average distance to closest provider of endoscopy or
mammography services in the county is included for each person in our empirical model,
reflecting the density of providers in their county. The source of the distance measure is the
freely available RTI Spatial Impact Factor Database (https://rtispatialdata.rti.org). As
documented in the database metadata, this county-specific measure is the unweighted
average distance (miles) over all ZIP codes with centroid in the county to closest provider
ZIP code centroid. The measure was calculated each year 2001-2006 using provider address
ZIP codes from 100% of physician carrier claims for Medicare patients’ utilization these
services. We assume that this average distance measure reflects the availability of these
providers and services to the entire population in an area. This variable is thus a direct
measure of the potential interaction between people and their healthcare environments,
indicated by the horizontal arrow across the figure. Other variables defined at the county and
state levels correspond to other portions of Figure 1.
Table 2 summarizes the county-level variables included in the modeling, by state, with
sources. There is considerable variability in these county-level variables across the 11 states.
These include the proportion of the population enrolled in HMOs, the proportion of the
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cancer population that are vulnerable (dually eligible or have disability or ESRD), the
proportion of Medicare FFS enrollees who used BC or CRC screening in 2001, the
proportion of persons aged 80+, and a residential segregation index. The segregation index,
defined at the county level, is matched to a person's race or ethnicity in the modeling. This
variable (like distance to closest provider) is thus defined from the person's perspective and
is another measure of the direct interaction between people and their environments, captured
by the horizontal arrow in the figure.
The residential segregation measure we use, the isolation index, was defined by Massey and
Denton (1988). We obtained the measures from the RTI Spatial Impact Factor Database,
which includes all 5 dimensions of residential segregation as defined by Massey and
Denton, and at various spatial scales. This isolation index was calculated separately using
2000 Census of Populations data for Blacks, Asians, Hispanics, Pacific Islanders and Native
Americans, and all other races combined. Following Massey and Denton's approach, each
race or ethnicity's isolation index was defined relative to whites. We chose a measure from
the RTI database defined at the county level, which has values ranging from 0 to 1 and
where higher values represent greater isolation or segregation of minorities from whites
(Massey and Denton, 1988). Higher values represent higher probability that minorities live
among people of their same race or ethnicity; lower values represent more mixed
communities.
Massey and Denton's isolation, clustering, and dissimilarity indices have been used rather
extensively in social sciences research. Kramer and Hogue (2009) reviewed 39 studies of
ecological factors and social outcomes, and found that only two studies used a spatial
clustering measure, whereas eleven studies used an isolation index and twelve stuudies used
a dissimilarity index. The clustering index is more useful in studies of urban areas than in
studies (such as our own) spanning the urban-rural continuum.
To make our findings comparable with recent literature on late-stage cancer incidence (Kuo,
Mobley, and Anselin 2011; Dai, 2010; Haas et al, 2008), and cancer screening behavior
(Mobley et al, 2008a, 2008b, 2009), we chose to use the isolation index, which has been
interpreted as enhancing social cohesion or support when defined at the neighborhood level.
Several studies posit that conversely, residential isolation reflects an adverse environment
(Dai, 2010), but others posit that this can be modified positively by a high degree of
clustering into enclaves which enhances political empowerment (Bell et al, 2006; Laveist,
1992; 1993). This political empowerment interpretation may be valid for the isolation index
defined at the larger geopolitical unit (county) rather than in smaller areas, because a larger
index at a larger scale indicates a greater degree of spatial clustering. That is, the county
may reflect broader factors (than social support) such as political influence held by
minorities in the geopolitical units. One paper looking at the association between isolation
and breast cancer screening, where isolation was measured at successfully larger geographic
levels, concluded that level of aggregation does matter and that different levels may reflect
different ecological forces (Mobley et al, 2008a). Because we use county-level isolation
measures, we expect that these will reflect political influence held by minorities as a broader
manifestation of social cohesion and support.
Managed care health plan penetration is another important geographic risk factor. Managed
care plans are designed to promote preventive healthcare and case management so as to
improve allocation of resources. Early managed care plans provided more comprehensive
coverage of preventive care services, such as cancer screening, and the lower out-of-pocket
costs for these services encouraged their utilization relative to enrollees in traditional plans
(Luft, 1980; Wolinsky, 1980; Sullivan, 1999). Historical evidence suggests that enrollees in
Medicare managed care plans exhibited lower incidence of late-stage diagnoses for both
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breast and colorectal cancers than their peers enrolled in traditional FFS Medicare (Riley et
al, 1994, 1999; Roetzheim et al, 2008). More recently, however, the Government
Accountability Office found no difference in the utilization of cancer screening among
Medicare beneficiaries enrolled in Medicare managed care plans versus traditional FFS
plans (GAO, 2012). In these sorts of comparisons, it is essential to control for selection bias
among participants in the two plan types. In our own analysis which accounted for
participant characteristics known to be associated with selection bias, and modeled the
geographic variability across the different state health markets in the United States, we
found that managed care increased utilization of breast and colorectal cancer screening in
some markets, but not in others – so the evidence is mixed (Mobley et al, 2008b; Mobley et
al, 2010; Mobley et al, 2011). This is not surprising because states have varied insurance
regulations and these would be expected to have differential impacts of healthcare utilization
and outcomes, which is the basic tenet of this paper.
Managed care plans have had quite varied success at penetrating different regions of the
country, moreso in urban than in rural areas (Mobley and Frech, 2007). Managed care plans
have been shown to change the way that medicine is practiced in some highly penetrated
markets, a phenomenon that is described as ‘managed care market spillovers’ by economists
(Baker, 2003; Miller and Luft, 1994; Mobley et al, 2011). Spillover effects from managed
care have been variously defined as changes in practice patterns, costs, or the diffusion of
new technology relative to what might occur in markets with little managed care
penetration. Changes in practice patterns can spill over to people who are not insured by the
managed care plans but who are seen by the physicians who are affected by the information
the plans disseminate. Also, people may compare treatment options with and be influenced
by the care patterns received by their peers who are in managed care plans. In this way
managed care plans can impact the way medicine is practiced in their markets, impacting
adherence to screening guidelines and early detection of cancers by market participants,
whether or not they are enrolled in managed care plans. We expect a positive impact of
managed care penetration on cancer screening among our study population, resulting in a
negative association between managed care penetration and late stage of cancer at first
diagnosis, because screening promotes earlier detection of cancer.
We chose six state insurance laws or mandates to examine in the context of incidence of
late-stage cancer, as summarized in Table 3. Many laws and mandates passed during this
period were aimed at controlling managed care plan practices that restricted consumer
choice, among other things (NCSL, 2011) during a period of broad backlash against
managed care (Mobley and Frech, 2007). Among dozens of laws and mandates, we
restricted our focus to those which had a plausible hypothesized relationship with BC or
CRC stage at diagnosis and also exhibited variation across the 11 states. Another state-level
factor included in the models is the time elapsed since 1998 (in years) before a
comprehensive cancer control (CCC) plan was developed for the state, which varies across
states from 0 to 6 years. States with a later adoption of CCC plans are expected to have
lower impacts from those efforts, manifesting as lower cancer screening rates and higher
rates of late stage diagnosis.
Hypothesized Relationships—We investigate how state-level health economic
environments impact cancer outcomes through cross-level interactions with community-
level factors that are specified from the perspective of the cancer patients in those
communities. A recent paper predicting rates of late-stage BC diagnosis in California (Kuo,
Mobley, and Anselin, 2011) argued the importance of using ‘relevant contexts’ for people
making health care decisions, and found that women of different race or ethnicity living in
the same places faced different environments. These ‘relevant contexts’ are reflected in the
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horizontal arrow across Figure 1, which illustrates the spatial interaction between people and
their environments.
There are differences in the dynamics of breast and colorectal cancer screening factors
which impact outcomes and lead to different model specifications for BC and CRC. During
our study period, everywhere but Utah, most insurance fully covered mammography, or
there was at most a small copayment. For CRC screening by endoscopy (colonoscopy or
sigmoidoscopy) procedure costs and copayments were much higher. There are also
significant time costs involved in preparing for endoscopy, and a partner is needed for
transportation. There are also non-trivial risks associated with endoscopy which increase
with age, frailty and disease comorbidity, and these population demand factors influence the
diffusion and availability of these services (Mobley et al, 2011). To undergo preventive
CRC screening, the patient must come to the conclusion that the benefits exceed the costs
and risks, which may not happen without encouragement by healthcare providers and
evidence of provider safety (reputation). Having an established provider relationship is
expected to enhance continuity of care and to reinforce the importance of timely screening.
We expect that lower-income individuals, many of whom could be of minority status, will
be much less likely to utilize preventive CRC screening, and thus be more likely to present
at advanced stage at first diagnosis of cancer. Lower-income and minority elderly
individuals were more likely to enroll in Medicare managed care plans during this period
because Medicare managed care plans actively sought enrollees among minorities, targeting
their recruitment activities to poorer urban communities (AHIP, 2005; Atherly and Thorpe,
2005). This is important here because many of the insurance regulations and mandates were
enacted to protect consumers from stringent managed care insurance practices that
reportedly led to adverse outcomes (NCSL, 2011). We hypothesize that those states with
insurance laws and mandates that encourage quality competition among managed care plans
(plan report cards) or mandate that managed care plans provide good continuity of care will
benefit their vulnerable, low-income cancer populations. Even when these populations are
not enrolled in managed care plans, we expect that managed care spillovers will be
important geographic risk factors, as noted above.
H1: In states with either mandated report cards or continuity of care laws,
communities of vulnerable populations will exhibit lower late-stage CRC rates than
their counterparts in states without these mandates.
BC screening does not impose the same financial and non-financial barriers to utilization as
does CRC. Instead, social forces may be more important determinants of preventive care,
such as BC screening, and downstream incidence of cancer stage at diagnosis. We focus on
the probable impacts of residential isolation, which has been found important in recent
studies of BC screening and stage at diagnosis (Kuo, Mobley, and Anselin 2011; Haas et al,
2008; Mobley et al, 2008a, 2008b, 2009). We expect that women who live among people of
their same race or ethnicity have better geopolitical cohesion or social support, and may be
better informed about the importance of BC screening, or better motivated to utilize it,
resulting in lower probability of late-stage BC diagnosis. Also, a woman's information or
motivation may be enhanced by choosing her own doctor or having direct access to an OB/
GYN as a primary care provider. In addition, having the option for inpatient hospitalization
after mastectomy may reduce the fear of finding one has late-stage cancer, spurring
utilization of mammography.
H2: In states with either mandated inpatient hospitalization after mastectomy, any
willing provider laws, freedom of choice laws, or direct access to OB/GYN,
women with BC living is more segregated communities will exhibit lower late-
stage diagnosis rates than their peers in states without these mandates.
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Statistical Analysis—We estimated multilevel logistic models using data from person,
county, and state levels by pooling the data across the eleven states. We used the
Generalized Linear Latent and Mixed Model (Gllamm) procedure (Rabe-Hesketh et al,
2004) in Stata (StataCorp, 2011) to fit random intercept models that allow both county and
state intercepts to vary. Because the response is dichotomous (yes or no for late stage cancer
diagnosis), we chose the logit link to model the response variable. In addition, we used the
adaptive quadrature integration option in Stata to obtain more accurate estimates (Rabe-
Hesketh and Skrondal, 2008). Because we hypothesize that the factors which impact the
incidence of late stage BC diagnosis may not be the same as those impacting CRC
diagnosis, we specify and estimate the BC and CRC models separately.
To reduce collinearity, we examined only one cross-level interaction between the county and
state variable(s) per model. For the CRC models, we included a cross-level interaction
between the county-level proportion of cancer population who were vulnerable (dually
eligible, diasabled, or with ESRD) and each state-level insurance mandate listed in H1. The
estimation results for CRC models are included in Table 4. For the BC models, with
estimates presented Table 5, we included a cross-level interaction between the county-level
isolation index of residential segregation, aggregated to county level from separate indices
matched to each woman's race or ethnicity, and each state-level insurance mandate listed in
H2. A simplified, representative equation for both the BC and CRC models is:
Where Yijk is log of the late-stage probability divided by early-stage probability for person i
in county j and state k, γ00 is the overall intercept term for the 3-level model, Xi represents
all personal level factors, Cj represents the contextual factors characterizing county areas j,
Sk represents the binary indicators characterizing state insurance environments and the CCC
plan implementation variable, eijk is the residual of the outcome variable Yijk, and μ0j and
μ0k are the unique random intercepts for the county and state levels in the model. The
residual eijk reflects within-county variation among cancer patients, including measurement
error and variation among people that is not explained by the model. The county and state
intercept terms are themselves random, with associated error terms ηj and ηk, which reflect
variation between counties and states, beyond what is explained by the model. The variances
of the three error terms are estimated among other parameters from the data.
As discussed in Gelman and Hill (2007, p 247), when there is very little county level
variation, the multilevel model reduces to a classic regression model with no group-level
indicators (complete pooling, ignores variation between counties). On the other extreme,
when the group-level coefficients vary greatly relative to their standard errors, the multilevel
model reduces to classic regression with group indicator variables (sometimes known as
fixed effects models, or the no-pooling model). In intermediate cases, the complete pooling
model ignores variation between counties, while the no-pooling/fixed effects model
overstates this variability, by overfitting the data in each county and making the individual
counties seem more different from one another than they actually are (Gelman and Hill,
2007, p 253). The multilevel model estimates are a compromise, producing area-level
intercepts that are a weighted average from results that would obtain under complete-
pooling and no-pooling models. This weighted average reflects both the relative amount of
information available for individual counties (county sample sizes) and the relative amount
of information available for the average of all the counties (number of counties). In the
weighted averages from samples where counties have less information (smaller samples),
the weighting pulls the county-level estimate closer to the state average. In the weighted
averages from samples where counties have lots of information (large samples), the
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corresponding county-level estimates are closer to the county averages. In intermediate
cases, the multilevel estimates lie between the two extremes and are thus more robust than
estimates produced by either complete pooling or non-pooling models. Thus, the multilevel
modeling approach used here accounts explicitly for the size of populations in counties, and
stabilizes the variance for those counties with small populations, producing robust county-
level estimates (Gelman and Hill, 2007). More specifically, in situations where the variance
estimate for area-level effects (i.e. variance of the μ0j and μ0k parameters) is small, using a
multilevel approach is most important because it allows intercept estimates to vary by group
yet estimates them more precisely (i.e. with lower variance as compared to ordinary
regression), especially for groups with small sample size. The intercept estimates are then
used with the fitted model to produce the county-level estimates.
There are other advantages from multilevel modeling. In fixed effects models, it is not
possible to include both group indicators and group characteristics. A multilevel model is a
compromise between these two extremes, with several advantages. A major advantage of
multilevel models is the ability to estimate a separate intercept for each place and also
include place-specific covariates in the same model. An additional advantage is the ability to
then interact the area-level covariates with the person-level covariates, to determine cross-
level interaction effects. Assuming a random distribution for the group-level intercepts
reduces the number of parameters estimated (relative to fixed effects) and the increased
parsimony of the model allows for greater flexibility in examining these higher-order effects
and their interactions. Another advantage of the multilevel model is that we can get
reasonable predictions for counties with small sample sizes, which would be difficult using
classic regression.
Another advantage of using the random-intercepts multilevel model is its utility in
accounting for selection (migration) of people into areas. For example, when there are no
omitted area-level effects and when people are randomly assigned to areas, any variation in
health outcomes between areas could be attributed to the areas themselves (Oakes, 2004, p.
1934). However, people are not randomly assigned to areas. People self-select their
locations so it is important to include compositional variables reflecting characteristics of
the study population, such as age, marital status, comorbidity, and socioeconomic status.
When these variables determine the selection behavior, then including them in the multilevel
model adjusts the predicted person-level outcomes (used to construct area-level rates) for
differences in neighborhood composition due to selection. Because the observed differences
in health outcomes between areas cannot be separated from the selection or biological
information of people residing there, including compositional variables as controls is
essential (Oakes, 2004: pp 1938-1939). The predicted area-level estimates of rates of late-
stage diagnosis from random effects models with both compositional and contextual factors
are thus particularly useful for reliably predicting areas with highest and lowest late-stage
cancer rates.
Results—Four models with statistically significant cross-level interaction effects are
reported here. Two significant models for CRC and two significant models for BC are
presented in Tables 4 and 5. Goodness of fit statistics (AIC) are nearly identical across the
CRC models (Table 4) and the BC models (Table 5). The tables present coefficient
estimates, which can be readily converted to odds ratios using exponentiation.
Using the CRC model results, the coefficient of γ2 is the mean effect of living in a more
vulnerable community (i.e. those counties with higher rates of dual eligibility, disability, or
ESRD among cancer patients),γ3 is the mean effect of regulation requiring the state
insurance mandate, and the coefficient estimate γ4 is the change in the effect of living in a
more vulnerable cancer community across states with and without the law (specified in the
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table columns). Living in a more vulnerable community (γ2) is associated with significantly
higher rates of late-stage CRC in both models. However, states with continuity of care or
provider report card laws had significantly lower rates of late-stage CRC among their most
vulnerable cancer communities. (The coefficient estimates γ4 for these interaction effects
from the continuity of care or provider report card laws models are -0.961 and -0.976,
respectively). This suggests that these laws protected the most vulnerable cancer patients by
improving information or the ability to maintain provider relationships and continuity of
care.
Using the BC model results, the coefficient of γ2 is the mean effect of women living in
more segregated community, γ3 is the mean effect of regulation requiring the state
insurance mandate, and the coefficient estimate γ4 is the change in the effect of living in a
more segregated community across states with the law relative to those without the law.
Living in a more segregated community (γ2 ) is negatively associated with late-stage BC
rates, suggesting a protective effect, but this is only statistically significant in the inpatient
stay law model. The interaction effects (γ4 ) reflecting states with mandated allowance for
inpatient hospitalizatioon following mastectomy or any willing provider laws had positive
associations, suggesting higher rates of late-stage BC among the most residentially
segregated cancer communities (i.e. those counties with higher indices of residential
isolation among women with cancer). This suggests that living in more segregated
communities, among women of same race or ethnicity as self, exhibited worse outcomes in
the states with these laws. States that enacted both laws include CT, GA, KY, and NJ, while
states enacting the inpatient stay law only were CA and NM (Table 3). This is puzzling, but
may reflect the fact that in cross-sectional studies, direction of causality cannot be
ascertained. These laws may have been enacted in some states with higher geopolitical
influence from highly segregated communities (including whites), because rates of late-stage
cancer and other adverse disease outcomes were so high.
To conduct the more complex assessment of net effects associated with state-level insurance
variables requires a combination of estimates evaluated at the means of the county-level
variable included in the interaction.iv As regards the continuity of care law, we find both
positive and negative net effects among the seven states that enacted this law, as compared
to states without this law (null effect). The three states with largest vulnerable population
proportions had negative (protective) net effects: CA (-0.02), KY (-0.04), and LA (-0.06);
those with smaller vulnerable population proportions had positive (not protective) net effects
(IA, MI, NJ, WA). However, nine states with report card laws saw consistently positive (not
protective) net effects, reflecting higher rates of late-stage CRC than states without this law
(with net effects ranging from about 0.07 to 0.22). Thus the continuity of care law seemed to
offer protective effects to vulnerable populations in some states, but provider report card
laws did not. For BC, four (of six) states mandating allowing inpatient care after
mastectomy saw negative net effects (lower rates of late-stage BC) than states without this
law, ranging from -0.02 to -0.08. Thus the inpatient stay law seemed to offer protective
effects to women in segregated communities in the four more racially mixed states among
the seven that had passed this law (CA, GA, NJ, NM -versus CT and KY). However, in the
second BC model, four (of four) states mandating any willing provider saw positive (not
protective) net effects, compared to states without this law, ranging from 0.13 to 0.16.
These CRC and BC model results suggest that state insurance laws do have significant
associations with late-stage cancer incidence, among the 11 state Registry populations
studied. The estimated coefficients must be interpreted cautiously, however, as statistical
ivDerivation of these net effects from the state insurance variables is calculated as follows. Model: Yijk= γ00 + γ1Xi + γ2 Cj + γ3
Sk + γ4 Sk* Cj + μ0j + μ0k + eijk d Yijk /d Sk , when Sk =1, = γ3 + γ4* (mean Cj); when Sk =0, = 0
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associations (rather than as causal factors) because our data are cross-sectional. However, as
described above, the model results can be used to robustly generate predicted late-stage rates
for counties, and provide information regarding which are the highest and lowest risk places
among counties in multiple states.
Spatial Translation of Findings from Spatial Analysis
We used results from the CRC model with continuity of care law, and the BC model with
inpatient stay following mastectomy law, to construct confidence intervals for each county's
predicted late-stage cancer rate, using a delete-1 Jacknife method.v Next, we sorted the
county-level predictions from lowest to highest value, and identified the lower and upper
quartiles from this distribution. Using the confidence intervals, we determined that the
counties in the lower quartile of the distribution had late-stage rates that were not
overlapping with those in the upper quartile of the distribution, suggesting a significant
difference between the counties in the upper and lower quartile groups (p<0.05).
In the graphics which follow, counties in the lower quartile (Q1) and in the highest quartile
(Q4) are shown from both the BC and CRC models together. A bivariate map is used to
display these two sets of predictions jointly, in Figures 2 and 3, below. The map legend is a
3x3 color grid that shows all combinations of Q1, Q4, or Q2-Q3 county designations, for all
counties and both cancer types. The counties colored black, bright red, bright blue, and
white (the four corners of the bivariate legend) are of most interest. Counties colored white
vWe ultimately want to use confidence intervals to assess whether particular counties have predicted values that are significantly
lower or higher than other counties. In order to obtain confidence intervals for the model's predicted county level probability of late-
stage disease at first cancer diagnosis, we used the delete-1 Jackknife method (Wolter 2007). The delete-1 Jackknife method provides
an efficient way to obtain reference samples and uses a replication procedure on these samples to derive distributions for particular
estimates of interest. The reference samples are the n combinations of different groups of counties that are possible when sequentially
dropping one from a group of n counties and using the remainder as a subsample (with sequential replacement).
The computation algorithm for the delete-1 Jackknife method is as follows. Each county is sequentially removed from the full data set.
This will produce n replicates (subsamples). For each of these subsamples, we estimate a multilevel model using a SAS GLIMMIX
procedure, allowing intercepts for both states and counties to be random. From each subsample model's output, we use the estimates of
the fixed effects and random intercepts to compute the county level predicted values, aggregated from the person-level predicted
values. Because the dependent variable is dichotomous (whether or not a person has late-stage disease at first cancer diagnosis), we
used the logit transformation to obtain the predicted probability of late-stage diagnosis for each county.
Finally, we used the set of n predicted values of late-stage diagnosis for each county to compute the Jackknife variance using the
following formula (Wolter 2007):
where pi is the predicted value for county i from each of the n subsamples, p̂ is the average of the pi for county i from all the
subsamples, and n is the number of counties in the entire sample.
After we obtain the Jackknife variance, we compute the confidence intervals for each county's predicted rate of late stage cancer
diagnosis using the following formula:
where α is the desired level of statistical significance. We use α/2 =0.025 to construct the two-tailed, 95% confidence interval for each
county's predicted rate.
The software packages that we had available to fit the models (SAS or STATA) do not appear to have the capability to produce the
desired variance estimates, or the set of variance-covariance matrices necessary for constructing them. We used the delete-1 jackknife
method instead of other options (such as bootstrapping) due to its ease of implementation (using SAS Programming) and our ability to
account for known sources of variances. That is, this replication method accounts for the random selection of counties and potential
intra-county correlation of person-level observations. A limitation is that the delete-1 jackknife method employed here only considers
between county variance, and does not directly account for between state variance, which may be producing a biased estimate.
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have predicted rates of late stage BC and CRC (both) in the lower quartile (Q1) of the
distribution across all counties in the 11 states. On the other extreme, counties colored black
have predicted late-stage cancer rates for both cancer types that are in the upper quartile
(Q4) of the distribution. The bright red color indicates that BC rates are in the lower quartile
while CRC rates are in the upper quartile, while the bright blue color indicates that BC rates
are in the upper quartile while CRC rates are in the lower quartile. Generally, the red colors
signal concerns for CRC while the blue colors signal concerns for BC. Results suggest that
states like California and Connecticut and Iowa (with lots of red and little blue) should focus
their CCC efforts more so on CRC prevention, while New Jersey (all blue) should focus
CCC efforts on BC prevention. Six other states show one or more counties colored black,
suggesting that there is concern regarding high late-stage rates for both cancers.
Spatial translation of findings from spatial analysis at multiple levels that allows
comparisons across states is a logical first step towards designing national intervention
strategies using targeted resources. While the county (our smallest unit of analysis) may be
so large that it masks spatial patterns within it, our broader scale multilevel analysis allows
direct comparisons across states. The following provides a specific example of why this is
useful for national policy. While the geographically specific concentrations of late-stage
breast cancers identified at sub-county locales in Connecticut are certainly important for
local CCC efforts, small-area analysis of Connecticut alone masks the fact that late-stage BC
rates in Connecticut are actually in the lowest quartile among the 11 states with SEER
Registries. Late-stage CRC is more of a concern for Connecticut, from a national
perspective (Figure 3). This study uses multilevel modeling including state factors and
allows a direct comparison of late-stage cancer rates across states. This more comprehensive
multilevel analysis can help direct targeted resources at a national level toward those states
exhibiting the worst rates of late-stage disease.
Limitations
There are several limitations for these analyses. First, the results pertain to the populations
studied in the 11 SEER Registry Regions and cannot be generalized. In some cases, only
partial states are covered by the Registries, and results cannot be generalized to the rest of
these states. Next, because our data are not longitudinal, we cannot infer causal
relationships. Third, because of restrictions in available data and constraints in computing
capability, we use the county to reflect communities in our modeling, whereas smaller units
or areas crossing county boundaries may be more appropriate for measuring preventive
health markets. Fourth, the small sizes of minority populations with cancer within some
states precluded separate analyses of Hispanic, Asian, or Native American subgroups, which
were combined with ‘other’ races and ethnicities (which include persons of unknown race)
in the modeling. In future, using a longer time span, more complete coverage of states and
additional states in the analysis, it may be possible to look at these races and ethnicities in
more detail. Finally, by using the linked SEER-Medicare data, persons with no sort of
eligibility for Medicare or Medicaid are not included in the analysis. Thus privately insured
or uninsured individuals are not included in our study. While the population aged 65+ with
cancer is well-represented in the SEER Registry regions, the population under age 65 is not
well represented. Thus findings cannot be generalized and future studies using population-
based data are warranted.
Summary and Conclusions
In this paper, we use spatial analysis to answer questions related to both Why and Where
disparities in late-stage BC and CRC diagnoses are observed. In answer to Why, we focus
on state-level insurance factors and spatial interactions among the cancer population and
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their environment. Longer distances to closest provider of screening services are associated
with significantly higher odds of late-stage diagnosis for both cancers, while living among
persons of similar race or ethnicity seems to confer some protective effects for women with
BC. Findings from these 11 states suggest that characteristics of state insurance
environments may be significantly associated with cancer outcomes. We find that, ceteris
paribus, as regards late stage BC the inpatient stay law seems to offer protective effects to
women in segregated communities in the more racially mixed states that have passed this
law. Significantly negative net effects of state law were predicted for CA (-0.07), GA
(-0.03), NJ (-0.01), and NM (-0.07). As regards late-stage CRC, we find that, ceteris paribus,
the continuity of care law seems to offer protective effects to vulnerable cancer communities
in the three states with the largest vulnerable population proportions. Significantly negative
net effects of state law were predicted for CA (-0.02), KY (-0.04), and LA (-0.06).
In answer to Where, the random intercepts estimator used here accounts for ‘compositional’
characteristics of people in counties to yield estimates of county-level rates of late stage BC
or CRC diagnosis that are adjusted for sample selection as well as sample size. The
predicted rates of late-stage diagnosis from the model are thus smoothed relative to the
distribution of raw rates. The derived variances of the point estimates used to construct the
confidence intervals are quite narrow in most cases (plot available from authors upon
request). Using the estimates, we identified counties where the predicted rates of late-stage
outcomes were in the upper and lower quadrants of the distribution, and using these
produced maps showing the bivariate distribution of these predictions across both cancer
types. Figures 2 and 3 demonstrate that some states have high risk for late-stage diagnoses in
both cancers, while others seem to have problems with either BC or CRC.
This study uses population-based data, rather than survey sample data, to model actual
disparities in the distributions of BC and CRC outcomes, namely the late-stage cancer at
first cancer diagnosis. Although data were only available for 11 states, the findings still
allow some generalizable findings. First, there is considerable heterogeneity across states,
and across counties within states, in the rates of late-stage cancer diagnosed for these two
cancer types. Second, the health insurance environment varies considerably across states,
and variation in health insurance regulation and mandates is associated with cancer
outcomes. Thus, a closer look at the state-level policy variables, preferably in a model that
encompasses all 50 states, is warranted.
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Figure 2. Predicted County Rates of Late-Stage BC and CRC in California, Utah, and New
Mexico
The counties colored black, bright red, bright blue, and white (the four corners of the
bivariate legend) are of most interest. Counties colored white have predicted rates of late
stage BC and CRC (both) in the lower quartile (Q1) of the distribution across all counties in
the 11 states. On the other extreme, counties colored black have predicted late-stage cancer
rates for both cancer types that are in the upper quartile (Q4) of the distribution. The bright
red color indicates that BC rates are in the lower quartile while CRC rates are in the upper
quartile, while the bright blue color indicates that BC rates are in the upper quartile while
CRC rates are in the lower quartile. Generally, the red colors signal concerns for CRC while
the blue colors signal concerns for BC.
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Figure 3. Predicted County Rates of Late-Stage BC and CRC in Iowa, Kentucky, Louisiana,
Connecticut, and New Jersey
The counties colored black, bright red, bright blue, and white (the four corners of the
bivariate legend) are of most interest. Counties colored white have predicted rates of late
stage BC and CRC (both) in the lower quartile (Q1) of the distribution across all counties in
the 11 states. On the other extreme, counties colored black have predicted late-stage cancer
rates for both cancer types that are in the upper quartile (Q4) of the distribution. The bright
red color indicates that BC rates are in the lower quartile while CRC rates are in the upper
quartile, while the bright blue color indicates that BC rates are in the upper quartile while
CRC rates are in the lower quartile. Generally, the red colors signal concerns for CRC while
the blue colors signal concerns for BC.
Mobley et al. Page 22









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Mobley et al. Page 26
Table 4
Comparison of Two State Insurance Variable Models for Late Stage CRC
Outcome: whether person was diagnosed with late stage colorectal cancer
during 2000-2005.
state law: continuity of care state law: plan report card
Covariate Coeff P-val Coeff P-val
Person level variables
female (versus male) 0.042 0.001 0.042 0.001
under age 65 category(versus 80+) -0.062 0.028 -0.062 0.027
age65-79 category (versus 80+) -0.043 0.002 -0.043 0.002
married -0.080 0.000 -0.081 0.000
Black (versus white) 0.125 0.000 0.127 0.000
any other race or ethnicity (versus white) 0.062 0.013 0.063 0.011
Distance to closest endoscopy provider 0.004 0.005 0.005 0.004
County level variables
proportion population in managed care health plans 0.324 0.000 0.303 0.000
proportion Medicare FFS population with CRC screening -0.012 0.134 -0.012 0.152
γ2: proportion vulnerable cancer population (dual, disabled, ESRD) 1.090 0.018 0.846 0.004
proportion of census population age 80+ 0.567 0.262 0.621 0.193
State level variables
Years that elapsed before a CCC plan was implemented in state 0.021 0.254 0.033 0.004
γ3: regulation requiring state law or mandate (see column headings) 0.192 0.071 0.320 0.001
Cross-level interaction
γ4 : Interaction of vulnerable county proportion and state law or -0.961 0.005 -0.976 0.006
Goodness of Fit (AIC)
* 146153.0 146149.2
*
Goodness of Fit provided by re-estimation using SAS GLIMMX procedure
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Table 5
Comparison of Two State Insurance Variable Models for Late Stage BC
Outcome: whether the person diagnosed with late stage BC
during 2000-2005.
State law: allow inpatient stay
following mastectomy
State Law: any willing provider
Covariate Coeff P-val Coeff P-val
Person level
Person is dually eligible and/or has disability or end-stage renal
disease
0.344 0.000 0.345 0.000
person is in the under age 65 category (versus 80+) -0.114 0.000 -0.115 0.000
person is in the age65-79 category (versus 80+) -0.129 0.000 -0.129 0.000
person is married -0.119 0.000 -0.119 0.000
person is Black (versus white) 0.229 0.000 0.225 0.000
person is any other race or ethnicity (versus white) -0.065 0.089 -0.090 0.020
Distance to closest mammography provider 0.003 0.073 0.003 0.061
County level
proportion of population in managed care health plans -0.127 0.074 -0.162 0.017
proportion FFS population with BC screening -0.019 0.000 -0.017 0.000
γ2: Isolation index of residential segregation: social support -0.257 0.007 -0.107 0.123
State level
γ3: regulation requiring state insurance law or mandate (see
column headings)
-0.251 0.004 -0.035 0.664
Cross-level interaction
γ4: Interaction of social support and state insurance variable 0.311 0.002 0.220 0.019
Goodness of Fit (AIC)
* 137839.6 137843.4
*
Goodness of Fit provided by re-estimation using SAS GLIMMX procedure
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